目前的做法和未来的趋势在虫过敏原免疫疗法
Kavita Reginald1, Fook Tim Chew2
1Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway 47500, Selangor, Malaysia.
Molecular immunology
|July 22, 2023
概括
虫过敏免疫疗法显示出长期缓解的希望,但目前的治疗是漫长的,并有副作用. 未来的方法侧重于精确的诊断和有针对性的治疗,以提高疗效和安全性.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 环境健康 环境健康
背景情况:
- 虫过敏是过敏性鼻炎的重要触发因素,特别是在热带地区,影响社会经济环境较低的儿童和年轻人.
- 目前用于过敏的免疫治疗是漫长的,并带有不良反应的风险,缺乏单一的主导过敏原使治疗复杂化.
结论:
- 改善免疫疗法需要转向个性化医学,专注于精确的过敏原识别和量身定制的治疗策略.
- 目标是提高治疗效率,尽量减少不良影响,从而改善受影响个体的生活质量.
相关概念视频
Allergic Reactions
27.8K
Overview
27.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
351
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
351
Cross-reactivity
31.3K
Overview
31.3K


